Aphexda Approved in Us to Improve Autologous Stem Cell Transplants
Oct 10th, 2023
Aphexda (motixafortide) from BioLineRx has been given U.S. approval in conjunction with filgrastim (G-CSF) to facilitate autologous hematopoietic stem cell transplant (AHSCT) for multiple myeloma patients. Effective bloodstream mobilisation of...